What are the South African guidelines for using 20% lipid emulsion (Intralipid) in local anesthetic systemic toxicity or intra‑arterial infiltration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

South African Guidelines for Intralipid in Local Anesthetic Toxicity

While no specific South African guidelines are provided in the evidence, the international standard—which South Africa would follow—is to use 20% intravenous lipid emulsion (ILE) as a critical intervention for life-threatening local anesthetic systemic toxicity (LAST), particularly from bupivacaine. 1, 2

Primary Recommendation

Administer 20% lipid emulsion immediately for life-threatening LAST, especially when cardiovascular toxicity is present. The 2025 American Heart Association guidelines explicitly state that 20% ILE is efficacious in resuscitation of life-threatening local anesthetic toxicity 2. This represents the current international standard that South African practitioners should follow.

Dosing Protocol

Based on the most recent AHA guidelines 2, the dosing for 20% ILE in LAST is:

Initial bolus:

  • 1.5 mL/kg (approximately 100 mL for a 70 kg adult) given over 2-3 minutes
  • If cardiovascular collapse persists, repeat bolus up to 2 additional times

Continuous infusion:

  • 0.25 mL/kg/min (approximately 18 mL/min for 70 kg adult)
  • Continue until hemodynamic stability is restored
  • Maximum recommended dose: approximately 10 mL/kg over the first 30 minutes

Clinical Context

When to Use ILE

Administer 20% lipid emulsion for:

  • Cardiovascular toxicity: Arrhythmias, severe bradycardia, hypotension, cardiac arrest
  • Severe CNS toxicity progressing to cardiovascular compromise: Seizures with hemodynamic instability
  • Cardiac arrest refractory to standard ACLS

The evidence strongly supports early administration—do not wait for full cardiac arrest 2. Bupivacaine toxicity is particularly responsive to ILE therapy due to its high lipophilicity and potent cardiotoxicity 2.

Concurrent Management

ILE is an adjunct, not a replacement for standard resuscitation 1, 2:

  1. Stop local anesthetic administration immediately
  2. Call for help and prepare for advanced resuscitation
  3. Airway management: Prevent hypoxia and acidemia, which worsen toxicity 2
  4. Seizure control: Administer benzodiazepines for seizures 2
  5. Sodium bicarbonate: Consider 1-2 mEq/kg IV for severe cardiovascular toxicity or wide QRS 2
  6. Modified ACLS: Reduce epinephrine doses (<1 mcg/kg), avoid vasopressin, calcium channel blockers, beta-blockers, and propofol 2
  7. VA-ECMO: Initiate early if refractory to other measures 1, 2

Critical Caveats

Do NOT use propofol as a substitute for 20% ILE. Propofol contains only 10% lipid emulsion, and achieving therapeutic doses would require 10-20 times the induction dose, causing severe CNS and cardiovascular depression 2.

Hypoxia and acidemia dramatically increase local anesthetic cardiotoxicity, particularly with bupivacaine 2. Aggressive airway management and ventilation are therefore essential components of treatment.

Post-resuscitation monitoring: Observe patients for at least 4-6 hours after apparent recovery, as recurrent cardiovascular collapse can occur due to redistribution of local anesthetic from lipid compartments 3.

Intra-arterial Infiltration

The evidence provided does not specifically address intra-arterial infiltration of local anesthetics. This is a distinct entity from systemic toxicity and typically requires:

  • Immediate cessation of injection
  • Consideration of vasodilators and anticoagulation
  • Consultation with vascular surgery

ILE has not been established as beneficial for intra-arterial injection complications.

Availability and Preparation

20% lipid emulsion should be immediately available wherever large doses of local anesthetics are administered 4, 5. This includes operating rooms, procedure suites, emergency departments, and pain clinics. Pre-prepared emergency kits with dosing charts facilitate rapid administration during crisis situations 6.

Related Questions

What ACLS adjustments are recommended for local anesthetic systemic toxicity (LAST)?
What are the latest updates in the management of local anesthetic systemic toxicity (LAST)?
What is the recommended dosing of 20% lipid emulsion (Intralipid®) for managing local anesthetic systemic toxicity (LAST) in adults and children?
What is the recommended intravenous midazolam dosing for a patient experiencing seizures due to local anesthetic systemic toxicity?
What is the most likely diagnosis in a patient who develops a metallic taste and dizziness immediately after an interscalene nerve block for pain control?
What is the recommended first-choice insulin (e.g., basal insulin such as insulin glargine) when initiating insulin therapy?
What are the step‑by‑step treatment guidelines for a diabetic patient, and how should I evaluate and manage a patient presenting with a blood glucose level of 300–500 mg/dL?
What essential knowledge and techniques should an intern learn to practice in an anesthesia ward, covering all types of anesthesia?
Does Pataday (olopatadine) help with mild eyelid swelling?
What is the evidence‑based treatment for tinea capitis caused by Trichophyton rubrum or Trichophyton violaceum?
In a 26‑year‑old woman, 4 months postpartum, with mildly elevated alkaline phosphatase, moderately elevated aspartate aminotransferase and alanine aminotransferase, normal lipid panel, normal complete blood count, and negative hepatitis serologies, what is the differential diagnosis and appropriate next steps in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.